Literature DB >> 1676481

Reversal of mu-opioid-mediated respiratory depression by alpha 2-adrenoceptor antagonism.

S Vonhof1, A L Sirén.   

Abstract

The present study was performed in order to evaluate the effects of the selective alpha 2-adrenoceptor antagonist 6-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) on dermorphin-induced analgesia, respiratory depression and inhibition of locomotor activity in the conscious rat. Intracerebroventricular (icv) administration of dermorphin (3 nmol/rat) decreased respiration rate and relative ventilatory minute volume maximally by 38% and 50% of baseline respectively. SK&F 86466 dose-dependently reversed the dermorphin-induced depression of ventilatory parameters, while SK&F 86466 exerted no effect on dermorphin-induced analgesia or depression of locomotor activity due to catalepsia. It appears, therefore, that alpha 2-adrenoceptors selectively interact with mu 2-opioid-receptor mediated effects, such as respiratory depression, but are not involved in the modulation of mu 1-opioid-related effects, such as supraspinal analgesia and depression of locomotor activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676481     DOI: 10.1016/0024-3205(91)90024-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Differences in morphine reinforcement property in two inbred rat strains: associations with cortical receptors, behavioral activity, analgesia and the cataleptic effects of morphine.

Authors:  S K Sudakov; S R Goldberg; E V Borisova; L A Surkova; I V Turina; G I Elmer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  L-cysteine methyl ester overcomes the deleterious effects of morphine on ventilatory parameters and arterial blood-gas chemistry in unanesthetized rats.

Authors:  Paulina M Getsy; Santhosh M Baby; Walter J May; James N Bates; Christopher R Ellis; Michael G Feasel; Christopher G Wilson; Tristan H J Lewis; Benjamin Gaston; Yee-Hsee Hsieh; Stephen J Lewis
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

Review 3.  Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants.

Authors:  Mohammad Zafar Imam; Andy Kuo; Maree T Smith
Journal:  F1000Res       Date:  2020-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.